Prediction: This $43 Billion Bet Will Help Pfizer Stock Take Off in 2025.

Pfizer (NYSE: PFE) became a stock market star in early pandemic days as it brought the first coronavirus vaccine to market. The company generated billions of dollars in revenue thanks to its coronavirus vaccine and treatment, even reaching a record of more than $100 billion in total company revenue in 2022.But in recent times, Pfizer's seen its earnings and share price decline along with demand for its coronavirus products. On top of this, some of Pfizer's blockbuster products are losing exclusivity later this decade, and this will weigh on revenue. Share performance has reflected this, with the stock declining more than 50% over the past three years.The company hasn't been sitting around watching this happen, though. Instead, it has focused on reviving growth and keeping the new momentum going over the long term. Pfizer even put $43 billion behind one particular program to strengthen its expertise in this key treatment area and supercharge growth. My prediction is that this bet will help Pfizer stock take off in 2025. Let's take a closer look.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool